Memorandum of Understanding With the U.S. Army Corps of Engineers, Mobile District, 29764-29769 [E8-11521]

Download as PDF 29764 Federal Register / Vol. 73, No. 100 / Thursday, May 22, 2008 / Notices rwilkins on PROD1PC63 with NOTICES General Function of the Committee: To provide advice and recommendations to the agency on FDA’s regulatory issues. Date and Time: The meeting will be held on June 10, 2008, from 8 a.m. to 4:30 p.m. Location: Hilton Washington DC North/Gaithersburg, Salons A, B, and C, 620 Perry Pkwy., Gaithersburg, MD. Contact Person: Karen F. Warburton, Center for Devices and Radiological Health (HFZ–460), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 240–276–4238, or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area), code 3014512396. Please call the Information Line for up-to-date information on this meeting. A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the agency’s Web site and call the appropriate advisory committee hot line/phone line to learn about possible modifications before coming to the meeting. Agenda: The committee will discuss general issues concerning the postmarket experience with various contact lens care products. The discussion will include recommendations on contact lens care product development topics such as preclinical testing and clinical performance measures, and labeling for contact lenses and lens care products. FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA’s Web site after the meeting. Background material is available at https://www.fda.gov/ohrms/ dockets/ac/acmenu.htm, click on the year 2008 and scroll down to the appropriate advisory committee link. Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending VerDate Aug<31>2005 17:03 May 21, 2008 Jkt 214001 before the committee. Written submissions may be made to the contact person on or before June 5, 2008. Oral presentations from the public will be scheduled on June 10, 2008, between approximately 9:30 a.m. and 10 a.m. and between approximately 3:30 p.m. and 4 p.m. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before May 28, 2008. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by May 29, 2008. Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact AnnMarie Williams, Conference Management staff, 240–276–8932, at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at https://www.fda.gov/oc/advisory/ default.htm for procedures on public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [FDA No. 225–08–2000] Memorandum of Understanding With the U.S. Army Corps of Engineers, Mobile District AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between FDA and the U.S. Army Corps of Engineers, Mobile District. This MOU establishes a mutual framework governing the respective responsibilities of the parties for the provision of health services through the Corps’ Regional Occupational Health Center to FDA employees at the FDA Gulf Coast Seafood Laboratory. Goods and services the Corps may provide include, but are not limited to, physicals at ageappropriate intervals, referral of employees to private physicians, prevention programs related to health, and other related goods and services as meet the criteria and standards of the Public Health Service, immunizations for influenza and tetanus, and safety and environmental counseling DATES: The agreement became effective April 28, 2008. FOR FURTHER INFORMATION CONTACT: Julia Pryor, Center for Food Safety and Nutrition, rm. 122 (HFS–400), Food and Drug Administration, P.O. Box 158, One Iberville Dr., Dauphin Island, AL 36528, 251–694–4479. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU. Dated: May 15, 2008. Randall W. Lutter, Deputy Commissioner for Policy. [FR Doc. E8–11451 Filed 5–21–08; 8:45 am] Dated: May 13, 2008. Jeffrey Shuren, Associate Commissioner for Policy and Planning. BILLING CODE 4160–01–S BILLING CODE 4160–01–S PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\22MYN1.SGM 22MYN1 VerDate Aug<31>2005 17:03 May 21, 2008 Jkt 214001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4725 E:\FR\FM\22MYN1.SGM 22MYN1 29765 EN22MY08.005</GPH> rwilkins on PROD1PC63 with NOTICES Federal Register / Vol. 73, No. 100 / Thursday, May 22, 2008 / Notices VerDate Aug<31>2005 Federal Register / Vol. 73, No. 100 / Thursday, May 22, 2008 / Notices 17:03 May 21, 2008 Jkt 214001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4725 E:\FR\FM\22MYN1.SGM 22MYN1 EN22MY08.006</GPH> rwilkins on PROD1PC63 with NOTICES 29766 VerDate Aug<31>2005 17:03 May 21, 2008 Jkt 214001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4725 E:\FR\FM\22MYN1.SGM 22MYN1 29767 EN22MY08.007</GPH> rwilkins on PROD1PC63 with NOTICES Federal Register / Vol. 73, No. 100 / Thursday, May 22, 2008 / Notices VerDate Aug<31>2005 Federal Register / Vol. 73, No. 100 / Thursday, May 22, 2008 / Notices 17:03 May 21, 2008 Jkt 214001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4725 E:\FR\FM\22MYN1.SGM 22MYN1 EN22MY08.008</GPH> rwilkins on PROD1PC63 with NOTICES 29768 Federal Register / Vol. 73, No. 100 / Thursday, May 22, 2008 / Notices BILLING CODE 4160–01–C DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: May 14, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–11304 Filed 5–21–08; 8:45 am] BILLING CODE 4140–01–M National Institutes of Health rwilkins on PROD1PC63 with NOTICES Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, June 16, 2008, 8 a.m. to June 17, 2008, 5 p.m., Four Points Sheraton, 1201 K Street, NW., Washington, DC 20005 which was published in the Federal Register on May 2, 2008, 73 FR 24296–24298. The meeting will be held June 23, 2008. The meeting time and location remain the same. The meeting is closed to the public. VerDate Aug<31>2005 17:03 May 21, 2008 Jkt 214001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Initial Review Group; Subcommittee H—Clinical Groups. Date: July 14–15, 2008. Time: 6:30 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Timothy C. Meeker, MD, PhD, Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room E:\FR\FM\22MYN1.SGM 22MYN1 EN22MY08.009</GPH> [FR Doc. E8–11521 Filed 5–21–08; 8:45 am] 29769

Agencies

[Federal Register Volume 73, Number 100 (Thursday, May 22, 2008)]
[Notices]
[Pages 29764-29769]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-11521]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[FDA No. 225-08-2000]


Memorandum of Understanding With the U.S. Army Corps of 
Engineers, Mobile District

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is providing notice of 
a memorandum of understanding (MOU) between FDA and the U.S. Army Corps 
of Engineers, Mobile District. This MOU establishes a mutual framework 
governing the respective responsibilities of the parties for the 
provision of health services through the Corps' Regional Occupational 
Health Center to FDA employees at the FDA Gulf Coast Seafood 
Laboratory. Goods and services the Corps may provide include, but are 
not limited to, physicals at age-appropriate intervals, referral of 
employees to private physicians, prevention programs related to health, 
and other related goods and services as meet the criteria and standards 
of the Public Health Service, immunizations for influenza and tetanus, 
and safety and environmental counseling

DATES: The agreement became effective April 28, 2008.

FOR FURTHER INFORMATION CONTACT: Julia Pryor, Center for Food Safety 
and Nutrition, rm. 122 (HFS-400), Food and Drug Administration, P.O. 
Box 158, One Iberville Dr., Dauphin Island, AL 36528, 251-694-4479.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which 
states that all written agreements and MOUs between FDA and others 
shall be published in the Federal Register, the agency is publishing 
notice of this MOU.

    Dated: May 13, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
BILLING CODE 4160-01-S

[[Page 29765]]

[GRAPHIC] [TIFF OMITTED] TN22MY08.005


[[Page 29766]]


[GRAPHIC] [TIFF OMITTED] TN22MY08.006


[[Page 29767]]


[GRAPHIC] [TIFF OMITTED] TN22MY08.007


[[Page 29768]]


[GRAPHIC] [TIFF OMITTED] TN22MY08.008


[[Page 29769]]


[GRAPHIC] [TIFF OMITTED] TN22MY08.009

[FR Doc. E8-11521 Filed 5-21-08; 8:45 am]
BILLING CODE 4160-01-C

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.